Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 23 August 2011
Vol. 4, Issue 187, p. ec231
[DOI: 10.1126/scisignal.4187ec231]

EDITORS' CHOICE

Apoptosis Death by Acetylation

Nancy R. Gough

Science Signaling, AAAS, Washington, DC 20005, USA

ARD1, which is the catalytic subunit of the N-acetyltransferase complex NatA, has been implicated in promoting apoptosis, suggesting that protein acetylation may serve a regulatory role in this form of cell death. Technical limitations in detecting protein N-acetylation have hampered the investigation of this modification. Yi et al. developed a biochemical assay to detect N-acetylated proteins. Knockdown of ARD1 sensitized cells to apoptosis in response to DNA-damaging agents but not death induced by activation of death receptors. Using the subtiligase-based assay, which attaches biotin to nonacetylated free N termini of proteins, a decrease in the abundance of N-acetylated caspase 2 and other proteins, based on immunoblotting and mass spectrometry, was detected after ARD1 knockdown. Altering metabolism by knocking down enzymes involved in acetyl-CoA synthesis also resulted in a decrease in N-acetylation of caspase 2. An N-acetylation–deficient mutant of caspase 2 (A3P) exhibited a decrease in N-acetylation and failed to interact with RAIDD, an adaptor of the caspase activation complex. Because the antiapoptotic protein Bcl-xL alters metabolism, Yi et al. investigated the effect of overexpression and genetic knockout on N-acetylation of proteins implicated in apoptosis (caspases 2, 9, and 3, and the proapoptotic protein Bax, which interacts with Bcl-xL) and found that overexpression of Bcl-xL reduced N-acetylation of these proteins, whereas genetic knockout increased their N-acetylation. The reduction in N-acetylation in Bcl-xL–overexpressing cells was reversed by addition of acetyl-CoA–generating metabolites, and these metabolites increased the sensitivity of the Bcl-xL–overexpressing cells to caspase activation and apoptosis in response to DNA damage with doxorubicin. Global metabolic profiling using two complementary methods revealed that acetyl-CoA was decreased in Bcl-xL–expressing cells, whereas acetyl-CoA was increased in genetic knockout cells. Glucose labeling experiments suggested that Bcl-xL overexpression altered glucose metabolism such that glucose-derived citrate, a precursor of acetyl-CoA, was reduced. These data have implications for understanding how metabolic changes can promote tumorigenesis and suggest that Bcl-xL has dual roles in promoting cell survival, by inhibiting Bax-mediated mitochondrial permeabilization and by altering metabolism to reduce protein N-acetylation.

C. H. Yi, H. Pan, J. Seebacher, I.-H. Jang, S. G Hyberts, G. J. Heffron, M. G. Vander Heiden, R. Yang, F. Li, J. W. Locasale, H. Sharfi, B. Zhai, R. Rodriguez-Mias, H. Luithardt, L. C. Cantley, G. Q Daley, J. M. Asara, S. P. Gygi, G. Wagner, C.-F. Liu, J. Yuan, Metabolic regulation of protein N-alpha-acetylation by Bcl-xL promotes cell survival. Cell 146, 607–620 (2011). [Online Journal]

Citation: N. R. Gough, Death by Acetylation. Sci. Signal. 4, ec231 (2011).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882